CMRG Grant Opportunities

Research to Remission Grant

The Research to Remission Grant is designed to provide funding for research that may lead to a significant change in the understanding, diagnosis, and/or treatment of multiple myeloma. Each year, CMRG, with the support of its partners, provides funding for myeloma research. We welcome applicants who hold a Ph.D., M.D., D.V.M, or equivalent and have a demonstrated research environment suitable for their proposed study. For 2021, CMRG will be accepting applications for Real-World Evidence Research using the CMRG Database.

Supported by a research grant from Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.

2021 Grant Important Dates

Phase Date
Call for proposals December 3, 2021
Submission of study concept December 30, 2021
Review panel meeting January 19, 2022
Notification of Awards January 24, 2022
Award start date January 31, 2022